Dallah Healthcare Company (4004.SR) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Dallah Healthcare Company, with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | 23.59x | 31.03x | 46.44x | 48.01x | 26.14x | 42.76x |
| P/B Ratio | 3.11x | 4.22x | 5.22x | 6.62x | 3.62x | 2.36x |
| P/S Ratio | 3.12x | 4.56x | 5.68x | 5.30x | 3.21x | 3.15x |
| Profitability | ||||||
| Gross Margin | 34.9% | 37.6% | 36.7% | 36.0% | 36.1% | 34.1% |
| Operating Margin | 13.7% | 17.7% | 17.2% | 17.0% | 17.3% | 9.5% |
| Net Margin | 13.2% | 14.7% | 12.2% | 11.0% | 12.3% | 7.4% |
| EBITDA Margin | 19.3% | 22.1% | 21.5% | 20.7% | 21.3% | 22.0% |
| Liquidity | ||||||
| Current Ratio | 1.24x | 1.15x | 1.16x | 1.47x | 1.27x | 1.35x |
| Quick Ratio | 1.01x | 0.95x | 0.96x | 1.19x | 1.03x | 1.12x |
| Leverage | ||||||
| Debt/Equity | 0.96x | 0.58x | 0.62x | 0.99x | 1.01x | 0.87x |
YoY = year-over-year change. Source: FMP..